The London COPD Exacerbation Cohort

Recruiting now

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.

Key facts

Study ID

NCT02755974

Run by

Imperial College London

People needed

300

Starts

2009-01-01

Expected to finish

2026-12-31

Last updated by the study team

2022-06-21

Who can join

Age: 40 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of <0.70
• Able and willing to give informed and written consent

You may not qualify if…

• Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.
• Patients on Immunosuppressive medications or with active cancer
• Long term steroid therapy
• Age <40 years at recruitment

Where it is running

• National Heart and Lung Institute, Imperial College — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.